Virtu Financial LLC Allakos Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$4.3 - $8.27 $143,293 - $275,589	33,324 New	33,324 $148,000
Q1 2021 May 19, 2021	SELL	$109.73 - $153.66 $169,313 - $237,097	-1,543 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$79.58 - $152.45 $185,739 - $355,818	-2,334 Reduced 60.2%	1,543 $216,000
Q3 2020 Dec 11, 2020	BUY	$66.43 - $90.99 $257,549 - $352,768	3,877 New	3,877 $316,000
Q2 2020 Aug 07, 2020	SELL	$44.04 - $80.69 $94,641 - $173,402	-2,149 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$66.49 - $137.73 $142,887 - $295,981	2,149 New	2,149 $205,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.